After preliminary publications associated low ALT levels with lower skeletal muscle mass and increased long-term mortality in the older population,[40,41] several publications have described a more comprehensive association between decreased levels of ALT activity in the peripheral blood, sarcopenia, frailty, and an increased risk of all-cause mortality in middle-aged, heterogeneous populations. This evidence concerns the gene GPT and sarcopenia.